Overview
The life sciences industry is characterized, in large part, by unending innovation driven by the constant demand for new medical therapies. It is equally characterized by a robust but evolving regulatory framework in which the development of new technologies tends to outpace the laws needed to govern them.
In such a dynamic environment dominated by compliance issues and enforcement concerns, savvy legal advice is essential to an organization’s success.
At Epstein Becker Green, we have a tight-knit team of life sciences attorneys and advisors with strong backgrounds in science, industry, and government. Our clients are often on the leading edge of new technologies, and they trust us to guide them in areas where the regulatory picture remains unclear. We help them understand the law and its practical implications so they can adopt workable approaches to their legal, regulatory, and business issues.
Navigating the Regulatory Landscape
In an industry where stringent compliance obligations accompany every facet of a product’s development and commercialization, few companies can navigate the regulatory landscape without help. Our clients look to us to devise an overall regulatory strategy for their product, and we work with them to decide how that strategy will be implemented. How and by whom will the therapy be used? What research will be needed? What claims will need substantiating? What reimbursement schemes make the most sense? The answers to such questions—and countless similar ones—form the basis of each application for regulatory approval and provide our clients with roadmaps for addressing compliance issues going forward.
Our deep understanding of the applicable regulatory bodies and their enforcement mechanisms is key to every aspect of our client service. We represent clients in front of all such bodies, both in routine matters and in investigative inquiries. Our lawyers advise them on the development of their manufacturing and distribution systems. We arrange contracts defining their relationships with customers, vendors, and payors. We review their pricing options and sign off on advertising and promotional communications. Each of these efforts—and much more—is designed to ensure that all operations are fully optimized from both a business and a regulatory standpoint.
Serving Our Clients
Our team of life sciences attorneys and advisors serves organizations across the length and breadth of the life sciences industry, including:
- Academic centers
- Artificial intelligence companies
- Biotechnology companies
- Clinical laboratories
- Combination product manufacturers
- Digital health (IoT) companies
- Food and Dietary Supplements
- Genetics and Genomics
- Human cellular and tissue products (HCT/P) manufacturers
- In vitro diagnostic innovators
- Investors in the life sciences industry
- Medical device manufacturers
- Pharmaceutical and biologic manufacturers
- Precision medicine laboratories
- Research institutions and investigators
- Research services vendors (including contract research organizations and site management organizations
- Suppliers and distributors
- Telehealth companies
- Trade associations and industry coalitions
We cover a broad scope of products and services that fall within these general categories: research and development, clinical research support, product commercialization, FDA regulatory strategy, compliance and training, litigation, and transactions and capitalization.
Read less
Focus Areas
Services
- Academic and Clinical Research
- ADA and Public Accommodations
- Affirmative Action/OFCCP Compliance
- Appellate
- Business Torts, Competition & Trade Secrets
- Class Actions
- Commercial and Contract Litigation
- Corporate & Transactional
- Corporate and Securities Litigation
- Corporate Compliance Program Development, Implementation, and Effectiveness
- Corporate Financing
- Corporate Governance
- Corporate Reorganization
- Cross-Border Data Transfers
- Cross-Border Transactions
- Cybersecurity Risk Assessment
- Data Asset Management
- Data Breach and Incident Response
- Data Breach/Cybersecurity Investigations & Litigation
- Data Protection
- DEI Compliance and Legal Counseling
- Dietary Supplement Litigation
- Digital Health
- Drug and Medical Device Coding, Coverage, and Payment
- Drug and Medical Device Distribution
- Drug and Medical Device Litigation
- Drug Pricing Policy & Reporting
- Employee Benefits and ERISA
- Employment Compliance Counseling
- Employment Litigation
- Employment Training
- Employment, Labor & Workforce Management
- ERISA – Retirement and Benefit Plan Litigation
- Executive Compensation
- FDA Inspections and Enforcement
- Federal Research Grants: Compliance, Investigations & Enforcement
- Financial Restructuring and Bankruptcy
- Foreign Multinational Counseling and Litigation
- General Counsel Services
- Health Care
- Health Care and Life Sciences Investigations and Enforcement
- Health Care and Life Sciences Investor Services
- Health Policy and Legislation
- Immigration
- Industry Research and Clinical Trials
- Insider Threats
- Intellectual Property
- Intellectual Property Litigation
- Internet of Things (IoT)
- Labor and Employment Due Diligence
- Labor Management Relations
- Life Sciences
- Life Sciences Due Diligence
- Litigation & Business Disputes
- Mergers, Acquisitions & Divestitures
- Occupational Safety and Health (OSHA)
- Pandemic Workforce Issues
- Pay Equity
- Privacy Compliance Strategies
- Privacy, Cybersecurity & Data Asset Management
- Product Marketing and Compliance
- Ransomware
- Real Estate
- Regulatory Strategy, Product Development, and Product Approvals
- Remote and Hybrid Work
- Social Media and the Workplace
- State Privacy Law Compliance
- Tax and Tax-Exempt Counseling
- Trade Secrets & Employee Mobility
- Wage and Hour
- Whistleblowing and Compliance
- White Collar Defense and Internal Investigations
- Workforce Government Relations
- Workforce Restructuring and Other Cost-Saving Mechanisms
- Workplace Investigations
Industries
Representative Experience
Our Team
Media
Events
Upcoming Events
Past Events
- March 30 to April 2, 2026
Insights
Insights
- PublicationsProposed Rules May Expand Access to Fertility Benefits, but Key Questions Remain13 minute read
- BlogsWatch: Fertility Benefits, Medical Marijuana, and Whistleblower Protections - Employment Law This Week4 minute read
- Firm Announcements
Epstein Becker Green Named to the BTI Client Service A-Team 2026 and Recognized Among the Law Firms Clients Love Most ...
2 minute read - BlogsCMS Codifies Drug Price Negotiation Program—With Modifications for 20298 minute read
- BlogsAt the Half: No Free Kicks in FDA’s 2026 Enforcement12 minute read
- Media CoverageRichard H. Hughes IV Quoted in Bloomberg Law on the CDC’s Revised Charter for Its Vaccine Advisory Committee2 minute read
- PublicationsRichard H. Hughes IV and Will Walters Co-Author MedPage Today Op-Ed on Heading Into Flu Season Without a Functioning ACIP ...2 minute read
- PublicationsConnecticut Private Employers: New Workplace Rules Take Effect October 113 minute read
- BlogsFederal Embryo Adoption Program Raises Potential Legal Questions for Reproductive Health7 minute read
- BlogsVermont’s H. 583 Restricts Private Equity and Hedge Funds with Ownership and Controlling Interests from Interfering with ...9 minute read
- BlogsWatch: DOJ’s New Self-Disclosure Rules: Decide Fast or Lose the Credit – Speaking of Litigation34 minute read
- BlogsFDA Regulations to Establish Minimum CGMP Requirements for Manufacturing, Packaging, Labeling, and Holding of Dietary ...5 minute read
- BlogsOIG Advisory Opinion 26-14 Offers Another Favorable Path for Patient Access Through Sponsored Testing12 minute read
- Media CoverageKate Gallin Heffernan Featured in Report on Medicare Compliance on a Proposed Federal Grants Overhaul That Could Trigger ...2 minute read
- Media CoverageConstance A. Wilkinson Quoted in Bloomberg Law on How a Proposed Medicare Drug-Pricing Rule Could Widen the Pool of ...2 minute read
- Media CoverageRichard H. Hughes IV Quoted in Law360 on HHS’s Bid to Reinstate Secretary Kennedy’s Vaccine Committee Appointments ...2 minute read
- BlogsIL HB 5000 Set to Expand Notice Requirements for Health Care Transactions in Illinois7 minute read
- BlogsWatch: States Are Now Writing the Workplace AI Rules - Employment Law This Week6 minute read
- BlogsWatch: Hemant Gupta Bridges the Gap Between Cutting-Edge Technology and Intellectual Property Protection7 minute read
- BlogsWill FDA Withdraw Its Wound Care Device Rule? Stakeholders Sure Hope So…7 minute read
- PublicationsCMS Issues Interim Final Rule on Medicaid Work Requirements16 minute read
- BlogsWatch: Agencies Step Up DEI Scrutiny, DOL Clarifies Overtime Rules, and California Court Limits PAGA Claims - Employment Law ...4 minute read
- PublicationsNon-Network Plans May Be on the ACA Exchanges: What the Final 2027 Payment Notice Means for Health Plans and Providers ...9 minute read
- BlogsPatent Infringement Lawsuit Alleges "Piracy" of AI-Driven Medical Technology7 minute read
- PublicationsVirginia Joins the Club: Paid Family and Medical Leave Coming Soon11 minute read
- Media CoverageSpreeha Choudhury Quoted in “Ongoing AAP, HHS Legal Battle Will Determine Future Health Care Action”2 minute read
- Firm Announcements
65 Epstein Becker Green Attorneys, 20 Practice Categories Recognized by Chambers USA for Delivering Excellence on Behalf of ...
6 minute read - Firm AnnouncementsElizabeth Scarola Recognized in 2026 Top 10 Under 40 Awards2 minute read
- BlogsWatch: EEO-1 Reports, Remote Work, and Non-Compete Restrictions in Tennessee - Employment Law This Week4 minute read
- Media CoverageHelaine Fingold Quoted in “No Surprises Act's New Rule Hands Win to Providers”2 minute read
- Media CoverageMedia Covers Six-Litigator Team’s Move to Epstein Becker Green7 minute read
- Firm AnnouncementsEpstein Becker Green Deepens Commercial and Health Care Litigation Bench with Six-Attorney Team6 minute read
- Media CoverageMarylana Saadeh Helou and Emily Chi Fogler Quoted in “Trump Administration Seeks to Overhaul Federal Grantmaking ...2 minute read
- BlogsFDA Warns Against “Over-Reliance” on AI Pharmaceutical Manufacturing . . . But How Much Reliance Is Too Much ...6 minute read
- BlogsFive Federal Cases Health Care and Life Sciences GCs Should Continue to Watch in 202611 minute read
- Media CoverageMelissa Jampol Quoted in “Surgeon Settles FCA Case Set in Motion by 'Data-Miner' Whistleblower”3 minute read
- PublicationsMedicaid Behavioral Health Investigations and Payment Suspensions in D.C. Are Increasing – How Providers Can Limit Risk ...2 minute read
- Media CoverageMedia Covers Bill Lewis's Move to Epstein Becker Green3 minute read
- Media CoverageMedia Covers Kim Harvey Looney's Move to Epstein Becker Green4 minute read
- Firm AnnouncementsVeteran Health Care Regulatory Attorney Kim Harvey Looney Joins Epstein Becker Green in Nashville5 minute read
- Firm AnnouncementsWilliam P. Lewis Joins Epstein Becker Green in Pittsburgh, Strengthening Labor and ERISA Capabilities4 minute read
- BlogsWatch: State Pay Transparency Laws in 2026 - Maine and Virginia Join the Ranks - Employment Law This Week5 minute read
- Media CoverageRichard Hughes Quoted in “HHS Withdraws New Rules for CDC Vaccine Panel”2 minute read
- BlogsCMS Announces Nationwide Moratoria on New Medicare Enrollment for Hospices, Home Health Agencies5 minute read
- BlogsMedicaid Behavioral Health Investigations and Payment Suspensions in D.C. Are Increasing – How Providers Can Limit Risk ...8 minute read
- Blogs‘Emilie’ Is Not a Psychiatrist: Pennsylvania Board of Medicine Alleges Unlawful Practice of Medicine by an AI Chatbot ...7 minute read
- BlogsWatch: Words Matter - How to Draft Arbitration Agreements That Hold Up in Court - Employment Law This Week5 minute read
- BlogsDOJ’s West Coast Strike Force to Target Health Care Fraud in Arizona, Nevada, and Northern California6 minute read
- PublicationsVaccine Litigation—Weighing the Consequences for the Public’s Health4 minute read
- BlogsFDA Proposal Would Leave Semaglutide, Tirzepatide, and Liraglutide Off 503B Bulks List6 minute read

